M
Mitotherapeutix
1 follower
Mitotherapeutix develops siRNA-based drugs that focus on addressing difficult disease targets.
Org chart
Jack Talley
Chief Executive Officer
Board & advisors
Robert Hennessey
Co-Founder & Chairman
Dan Wagner
Board Member
Fenel Eloi
Board Member
David Meeker
Advisor
Frank Marco
Advisor
Richard Gregory
Scientific Advisory Chair
Mercedes Rincon
Scientific Advisor
James Digregori
Scientific Advisor
Gerald Shadel
Scientific Advisor
Geoffrey White
Member
Maria Martinez-Chantar
Scientific Advisor
Wajahat Zafar Mehal
Scientific Advisor